心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688016 心脉医疗

已收盘 04-29 15:00:00

{"stockData":{"symbol":"688016","market":"SH","secType":"STK","nameCN":"心脉医疗","latestPrice":185.44,"timestamp":1714374000000,"preClose":174.88,"halted":0,"volume":2439003,"delay":0,"floatShares":71978100,"shares":82726299,"eps":6.6713,"marketStatus":"已收盘","marketStatusCode":5,"change":10.56,"latestTime":"04-29 15:00:00","open":184,"high":188.01,"low":183.65,"amount":453000000,"amplitude":0.0249,"askPrice":185.44,"askSize":16,"bidPrice":185.43,"bidSize":6,"shortable":0,"etf":0,"ttmEps":6.6713,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714440600000},"adr":0,"adjPreClose":174.88,"symbolType":"stock_kcb","openAndCloseTimeList":[[1714354200000,1714361400000],[1714366800000,1714374000000]],"highLimit":192.37,"lowLimit":157.39,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":82726253,"pbRate":3.79,"roa":"--","roe":"4.51%","epsLYR":6.81,"committee":0.148515,"marketValue":15341000000,"floatMarketCap":13348000000,"peRate":27.796682,"changeRate":0.0604,"turnoverRate":0.0339,"status":0,"afterMarket":{"amount":0,"volume":0,"close":185.44,"buyVolume":0,"sellVolume":0,"time":1714376039505,"indexStatus":"已收盘 04-29 15:30:00","preClose":174.88}},"requestUrl":"/m/hq/s/688016/wiki","defaultTab":"wiki","newsList":[{"id":"2431888386","title":"4月29日心脉医疗涨6.04%，工银战略转型股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431888386","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431888386?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:28","pubTimestamp":1714379303,"startTime":"0","endTime":"0","summary":"证券之星消息，4月29日心脉医疗涨6.04%，收盘报185.44元，换手率3.39%，成交量2.44万手，成交额4.53亿元。该股为医疗器械概念热股。重仓心脉医疗的前十大公募基金请见下表：该股最近90天内共有17家机构给出评级，买入评级12家，增持评级5家；过去90天内机构目标均价为227.35。根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共26家，其中持有数量最多的公募基金为工银战略转型股票A。该公募基金现任基金经理为杜洋。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900017014.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431888804","title":"心脉医疗涨6.04%，中泰证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431888804","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431888804?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:28","pubTimestamp":1714379298,"startTime":"0","endTime":"0","summary":"今日心脉医疗涨6.04%，收盘报185.44元。2024年3月29日，中泰证券研究员谢木青,于佳喜发布了对心脉医疗的研报《主动脉、外周等介入业务持续亮眼，6款创新产品有望率先收获》，该研报对心脉医疗给出“买入”评级。公司当前股价对应2024-2026年22、17、14倍，考虑到公司是国内血管介入龙头企业，竞争优势显著，未来有望凭借一系列主动脉以及外周介入创新产品维持高增长态势，维持“买入”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900017009.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431041529","title":"北向资金4月26日净买入心脉医疗1.69万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2431041529","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431041529?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:30","pubTimestamp":1714354236,"startTime":"0","endTime":"0","summary":"4月26日, 北向资金增持心脉医疗1.69万股，连续5日增持。截止当日收盘，沪股通共持有心脉医疗78.06万股，占流通股1.08%。沪股通增持金额前五个股分别为招商银行、贵州茅台、兴业银行、药明康德、三一重工。心脉医疗近5个交易日上涨2.64%，沪股通累计增持13.79万股；近20个交易日上涨0.19%，沪股通累计增持6.36万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042909362387bca6e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042909362387bca6e0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430605958","title":"平安证券：给予心脉医疗增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430605958","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430605958?lang=zh_cn&edition=full","pubTime":"2024-04-28 20:02","pubTimestamp":1714305743,"startTime":"0","endTime":"0","summary":"平安证券股份有限公司叶寅,倪亦道近期对心脉医疗进行研究并发布了研究报告《收入增长符合预期，多因素致利润率提升》，本报告对心脉医疗给出增持评级，当前股价为174.88元。　　维持“推荐”评级。最新盈利预测明细如下：该股最近90天内共有17家机构给出评级，买入评级12家，增持评级5家；过去90天内机构目标均价为227.35。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800008795.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430605555","title":"心脉医疗(688016)：收入增长符合预期 多因素致利润率提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2430605555","media":"平安证券","top":-1,"share":"https://www.laohu8.com/m/news/2430605555?lang=zh_cn&edition=full","pubTime":"2024-04-28 19:34","pubTimestamp":1714304060,"startTime":"0","endTime":"0","summary":"利润增长超出预期。高附加值产品销售占比提升使报告期内综合毛利率达到76.52%。年内，公司还有阻断球囊、髂静脉支架、外周滤器等多款产品预期获批上市，持续的产品新增与迭代保证了公司成长的持续性。费用率下降等因素导致利润率高于常规水平公司24Q1单季度毛利率为76.52%，主要系因为产品结构变化，高附加值产品相比去年同期增加较多。保持2024-2026年盈利预测为EPS 7.94、10.06和12.74元，维持“推荐”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404281934268b5dbe78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404281934268b5dbe78&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430610797","title":"心脉医疗(688016)3月31日股东户数1.04万户，较上期增加3.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430610797","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430610797?lang=zh_cn&edition=full","pubTime":"2024-04-27 17:09","pubTimestamp":1714208972,"startTime":"0","endTime":"0","summary":"证券之星消息，近日心脉医疗披露，截至2024年3月31日公司股东户数为1.04万户，较2月29日增加323.0户，增幅为3.19%。在医疗器械行业个股中，心脉医疗股东户数低于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.09万户。从股价来看，2024年2月29日至2024年3月31日，心脉医疗区间跌幅为2.49%，在此期间股东户数增加323.0户，增幅为3.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042700024712.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430695761","title":"心脉医疗：2024年第一季度净利润约1.84亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430695761","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430695761?lang=zh_cn&edition=full","pubTime":"2024-04-27 12:09","pubTimestamp":1714190985,"startTime":"0","endTime":"0","summary":"每经AI快讯，心脉医疗 4月27日发布一季度业绩公告称，2024年第一季度营收约3.58亿元，同比增加25.38%；归属于上市公司股东的净利润约1.84亿元，同比增加47.62%；基本每股收益2.23元，同比增加28.9%。道达号“个股趋势”提醒：1. 心脉医疗近30日内北向资金持股量增加5.31万股，占流通股比例增加0.08%；2. 近30日内共有1批机构对心脉医疗调研，合计调研的机构家数为143家。每经头条——拜登签了，不剥离就被禁！字节跳动紧急声明：不实！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042712213887b60c4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042712213887b60c4f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430227462","title":"微创医疗(00853)：心脉医疗一季度归母净利约1.84亿元 同比增长47.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430227462","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430227462?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:08","pubTimestamp":1714136882,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创医疗(00853)公布心脉医疗科技2024年一季度业绩，收入约3.58亿元，同比增长25.38%;归属于心脉医疗科技股权持有人的净利润约1.84亿元，同比增长47.62%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1112344.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430253312","title":"心脉医疗(688016.SH)发布一季度业绩 净利润1.84亿元 同比增长47.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430253312","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430253312?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:42","pubTimestamp":1714124541,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心脉医疗(688016.SH)披露2024年第一季度报告，该公司报告期实现营业收入3.58亿元，同比增长25.38%。归属于上市公司股东的净利润1.84亿元，同比增长47.62%。归属于上市公司股东的扣除非经常性损益的净利润1.78亿元，同比增长48.91%。基本每股收益为2.23元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111739.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430243107","title":"心脉医疗04月26日获主力加仓1423万元 环比增加1430.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430243107","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430243107?lang=zh_cn&edition=full","pubTime":"2024-04-26 15:18","pubTimestamp":1714115896,"startTime":"0","endTime":"0","summary":"心脉医疗今日主力资金净流入1423万元，连续3日净流入，上一交易日主力净流入93万元，今日环比增加1430.11%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为36.36%，平均涨幅为1.88%。该股近5个交易日上涨2.64%，主力资金累计净流入779万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入812万元，其中净流入天数为12日。该行业中净流入前三个股分别为迈瑞医疗、心脉医疗、新产业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042615282887b26ec0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042615282887b26ec0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430411282","title":"北向资金4月24日净买入心脉医疗1.53万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2430411282","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430411282?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:30","pubTimestamp":1714008631,"startTime":"0","endTime":"0","summary":"4月24日, 北向资金增持心脉医疗1.53万股，连续3日增持。截止当日收盘，沪股通共持有心脉医疗74.66万股，占流通股1.03%。沪股通增持金额前五个股分别为中国平安、海尔智家、农业银行、招商银行、万华化学。心脉医疗近5个交易日上涨3.94%，沪股通累计增持11.20万股；近20个交易日上涨2.64%，沪股通累计增持3.21万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042509355687acf048&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042509355687acf048&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428301551","title":"心脉医疗获融资买入0.13亿元，近三日累计买入0.27亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428301551","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2428301551?lang=zh_cn&edition=full","pubTime":"2024-04-18 08:24","pubTimestamp":1713399877,"startTime":"0","endTime":"0","summary":"4月17日，沪深两融数据显示，心脉医疗获融资买入额0.13亿元，居两市第601位，当日融资偿还额0.10亿元，净买入256.02万元。最近三个交易日，15日-17日，心脉医疗分别获融资买入0.06亿元、0.08亿元、0.13亿元。融券方面，当日融券卖出0.19万股，净买入0.52万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418082456878c3b55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418082456878c3b55&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428625113","title":"心脉医疗04月17日获主力加仓2198万元 环比增加2580.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428625113","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428625113?lang=zh_cn&edition=full","pubTime":"2024-04-17 15:18","pubTimestamp":1713338307,"startTime":"0","endTime":"0","summary":"04月17日, 心脉医疗股价涨0.87%，报收171.13元，成交金额1.46亿元，换手率1.19%，振幅3.22%，量比1.27。心脉医疗今日主力资金净流入2198万元，连续3日净流入，上一交易日主力净流入82万元，今日环比增加2580.49%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为40.00%，平均涨幅为1.88%。该股近5个交易日下跌4.59%，主力资金累计净流出495万元；近20日主力资金累计净流出623万元，其中净流出天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171526008b2dc9c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171526008b2dc9c8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427586864","title":"北向资金4月15日净买入心脉医疗3.73万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427586864","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427586864?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:30","pubTimestamp":1713231034,"startTime":"0","endTime":"0","summary":"4月15日, 北向资金增持心脉医疗3.73万股，连续3日增持。截止当日收盘，沪股通共持有心脉医疗68.74万股，占流通股0.95%。沪股通增持金额前五个股分别为贵州茅台、中国建筑、山西汾酒、兴业银行、招商银行。心脉医疗近5个交易日下跌2.90%，沪股通累计增持3.24万股；近20个交易日下跌4.77%，沪股通累计减持2.32万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160934468781ded8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160934468781ded8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427855934","title":"手机厂生产汽车？如何理解“跨次元”制造？","url":"https://stock-news.laohu8.com/highlight/detail?id=2427855934","media":"银华基金","top":-1,"share":"https://www.laohu8.com/m/news/2427855934?lang=zh_cn&edition=full","pubTime":"2024-04-16 07:44","pubTimestamp":1713224651,"startTime":"0","endTime":"0","summary":"一家以智能手机和智能家居产品闻名的科技企业，其进军汽车行业的消息一经发布，便引起了市场的广泛关注和热议。产业融合下，“跨次元”的企业生产出的产品具有创新性、多样性和高度集成的优势。通过高新技术的深度整合，“跨次元”企业能够快速响应市场变化，满足消费者对于个性化和智能化的需求。六、以上基金由银华基金依照有关法律法规及约定申请募集，并经中国证券监督管理委员会许可注册。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041607421687e808af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041607421687e808af&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426710964","title":"北向资金4月10日净卖出心脉医疗2.57万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2426710964","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426710964?lang=zh_cn&edition=full","pubTime":"2024-04-11 09:30","pubTimestamp":1712799035,"startTime":"0","endTime":"0","summary":"4月10日，北向资金减持心脉医疗2.57万股连续5日减持。截止当日收盘，沪股通共持有心脉医疗62.01万股，占流通股0.86%。沪股通减持金额前五个股分别为中国中免、贵州茅台、斯达半导、澜起科技、恒立液压。心脉医疗近5个交易日下跌4.61%，沪股通累计减持11.74万股；近20个交易日下跌3.75%，沪股通累计减持10.52万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110934498b0d6235&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110934498b0d6235&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426453835","title":"心脉医疗04月10日主力资金流入45万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2426453835","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426453835?lang=zh_cn&edition=full","pubTime":"2024-04-10 15:18","pubTimestamp":1712733525,"startTime":"0","endTime":"0","summary":"04月10日, 心脉医疗股价跌1.17%，报收179.37元，成交金额6677万元，换手率0.52%，振幅1.98%，量比0.65。心脉医疗今日主力资金净流入45万元，连续3日净流入，上一交易日主力净流入96万元，今日环比减少53.12%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为44.44%，平均涨幅为1.88%。该股近5个交易日下跌4.61%，主力资金累计净流入545万元；近20日主力资金累计净流入1177万元，其中净流入天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410153425875f244f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410153425875f244f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426306651","title":"财信证券给予心脉医疗买入评级 业绩稳健增长 新品研发不断推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2426306651","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2426306651?lang=zh_cn&edition=full","pubTime":"2024-04-09 15:11","pubTimestamp":1712646660,"startTime":"0","endTime":"0","summary":"财信证券04月09日发布研报称，给予心脉医疗（688016.SH，最新价：181.5元）买入评级。评级理由主要包括：1）主动脉支架实现稳健增长，术中支架和外周产品快速放量；2）创新研发投入加码，积极推进多款产品上市；3）全球化发展加速推进，海外市场覆盖率不断提升。风险提示：集采降价风险，产品研发上市进度不及预期，产品销售推广不及预期等。AI点评：心脉医疗近一个月获得6份券商研报关注，买入4家，增持1家。文章来源：每日经济新闻原标题：财信证券给予心脉医疗买入评级，业绩稳健增长，新品研发不断推进","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091519128b022aaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091519128b022aaa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426972323","title":"科创新动能助力经济回暖，中小盘成长赛道很有看头！","url":"https://stock-news.laohu8.com/highlight/detail?id=2426972323","media":"鹏华基金","top":-1,"share":"https://www.laohu8.com/m/news/2426972323?lang=zh_cn&edition=full","pubTime":"2024-04-09 07:54","pubTimestamp":1712620476,"startTime":"0","endTime":"0","summary":"但我国3月份制造业和非制造业的PMI指数都稳稳地站在了荣枯线之上，预示着经济继续回暖的良好前景。这样看来，科创新动能正逐渐替代传统产业成为我国经济增长新引擎，叠加全球科技创新浪潮推动，成长赛道投资逻辑依旧坚挺。而科创100指数以其独特的中小盘特性、鲜明的成长预期以及“硬科技”属性，无论是在短期还是中长期，都展现出了巨大的投资潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409075109861e3ff3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409075109861e3ff3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424764188","title":"心脉医疗(688016)业绩稳健兑现，外周产品有望不断获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2424764188","media":"中金公司","top":-1,"share":"https://www.laohu8.com/m/news/2424764188?lang=zh_cn&edition=full","pubTime":"2024-04-01 16:23","pubTimestamp":1711959825,"startTime":"0","endTime":"0","summary":"截至2023年底，公司产品已覆盖国内2,100家主要医院，核心产品Castor胸主分支支架/Minos腹主支架和PTX外周药球分别覆盖超过1,000/800/900家医院。截至1Q24，暂无主动脉支架多省联盟以上级别的集采出现。创新产品有望步入收获期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404011641088ae3557e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404011641088ae3557e&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-07-22","address":"上海市浦东新区康新公路3399弄1号","stockEarnings":[{"period":"1week","weight":0.0763},{"period":"1month","weight":0.009},{"period":"3month","weight":0.1239},{"period":"6month","weight":-0.0376},{"period":"1year","weight":0.0855},{"period":"ytd","weight":-0.0472}],"companyName":"上海微创心脉医疗科技(集团)股份有限公司","boardCode":"AI0035","perCapita":"6892股","boardName":"专用设备制造业","registeredCapital":"8272万元","compareEarnings":[{"period":"1week","weight":0.0225},{"period":"1month","weight":0.0236},{"period":"3month","weight":0.0998},{"period":"6month","weight":0.0298},{"period":"1year","weight":-0.0633},{"period":"ytd","weight":0.0464}],"survey":"　　上海微创心脉医疗科技(集团)股份有限公司主要从事主动脉及外周血管介入医疗器械的研发、生产和销售。主要产品为胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司自成立以来，一直深耕于主动脉及外周血管介入医疗器械领域，通过多年的经验积累，公司已发展成我国主动脉血管介入医疗器械的龙头企业。公司产品已进入全国约1900家医院，主动脉产品国内市场占有率已连续多年排名国产品牌第一。","serverTime":1714421569877,"listedPrice":46.23,"stockholders":"10443人(较上一季度增加3.19%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心脉医疗,688016,心脉医疗股票,心脉医疗股票老虎,心脉医疗股票老虎国际,心脉医疗行情,心脉医疗股票行情,心脉医疗股价,心脉医疗股市,心脉医疗股票价格,心脉医疗股票交易,心脉医疗股票购买,心脉医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}